Insider Trading & Ownership - Hickey Benjamin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hickey Benjamin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-16
Sale
2024-01-18
4:45 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
1,597$59.02$94,255117,028
(Direct)
View
2024-01-08
Sale
2024-01-09
5:54 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,090$58.92$123,143118,625
(Direct)
View
2023-12-13
Sale
2023-12-14
5:05 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,220$56.67$125,807103,694
(Direct)
View
2023-01-17
Sale
2023-01-19
09:45 am
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
1,566$42.38$66,36647,223
(Direct)
View
2023-01-09
Sale
2023-01-10
5:00 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,088$45.37$94,73348,789
(Direct)
View
2022-12-21
Sale
2022-12-21
9:20 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
3,248$40.41$131,26650,877
(Direct)
View
2022-01-18
Sale
2022-01-18
8:32 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
627$120.48$75,54352,797
(Direct)
View
2022-01-07
Sale
2022-01-07
8:27 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
1,964$135.94$266,98424,848
(Direct)
View
2021-03-19
Sale
2021-03-22
4:42 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,369$176.44$417,97856,928
(Direct)
View
2021-01-07
Sale
2021-01-08
7:46 pm
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,078$216.33$449,52519,789
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-30
Option Award(A)
2024-06-05
4:16 pm
N/A
2034-05-29
Mural Oncology plcMURAHickey Benjamin
Director
8,462$08,462
(Direct)
View
2024-05-30
Option Award
2024-06-03
10:23 am
N/A
2034-05-29
Mural Oncology plcMURAHickey Benjamin
Director
8,462$3.358,462
(Direct)
View
2024-03-10
Option Award
2024-03-12
5:45 pm
N/A
2028-03-10
BRISTOL MYERS SQUIBB COBMYHickey Benjamin
President, RayzeBio Org.
9,675$010,546
(Direct)
View
2024-03-01
Option Award
2024-03-04
5:57 pm
N/A
2027-03-01
BRISTOL MYERS SQUIBB COBMYHickey Benjamin
President, RayzeBio Org.
9,858$09,858
(Direct)
View

Ownership
2024-03-04
5:52 pm
N/A
N/A
BRISTOL MYERS SQUIBB COBMYHickey Benjamin
President, RayzeBio Org.
0$031,107
(Direct)
View
2024-01-23
Disposition
2024-01-23
8:37 pm
N/A
2033-01-20
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
162,484$00
(Direct)
View
2023-12-29
Option Award
2024-01-03
6:13 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
17,021$58.75120,715
(Direct)
View
2023-12-14
Option Award
2023-12-18
4:30 pm
N/A
2033-12-13
Mural Oncology plcMURAHickey Benjamin
Director
15,021$015,021
(Direct)
View
2023-08-09
Option Award
2023-08-10
4:23 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
22,297$37105,914
(Direct)
View
2023-01-20
Option Award
2023-01-24
4:00 pm
N/A
2033-01-20
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
81,850$0129,073
(Direct)
View
2022-12-19
Option Award
2022-12-21
9:20 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
19,149$050,877
(Direct)
View
2022-06-08
Option Award
2022-06-10
8:00 pm
N/A
2032-06-08
Surface Oncology Inc.SURFHickey Benjamin
Director
24,000$024,000
(Direct)
View
2022-01-14
Option Award
2022-01-18
8:32 pm
N/A
2032-01-13
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
28,576$052,797
(Direct)
View
2022-01-03
Option Award
2022-01-05
6:00 pm
N/A
2032-01-03
Surface Oncology Inc.SURFHickey Benjamin
Director
24,000$024,000
(Direct)
View
2021-03-19
Exercise
2021-03-22
4:42 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,369$114.3356,928
(Direct)
View
2021-03-19
Exercise
2021-03-22
4:42 pm
N/A
2030-01-05
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
2,369$056,928
(Direct)
View
2021-01-15
Option Award
2021-01-20
6:18 pm
N/A
2031-01-14
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
18,002$037,791
(Direct)
View
2020-01-06
Option Award
2020-01-08
9:06 pm
N/A
2030-01-05
Mirati Therapeutics Inc.MRTXHickey Benjamin
EVP, Chief Commercial Officer
54,352$054,352
(Direct)
View
(A) Indicate amendment filing.